Shares of InMode INMD fell 0.1% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 104.35% over the past year to $0.94, which beat the estimate of $0.75.
Revenue of $75,187,000 up by 59.97% year over year, which beat the estimate of $70,760,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Feb 10, 2021
Time: 08:30 AM
ET Webcast URL: https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10151158&linkSecurityString=e064a3345e
Technicals
Company's 52-week high was at $69.91
52-week low: $13.14
Price action over last quarter: Up 64.13%
Company Description
InMode Ltd is a provider of minimally-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions are designed to address three energy-based treatment categories including face and body contouring, medical aesthetics and women's health. The technologies offered by the company include BodyTite, Contoura, EmbraceRF, Optimas, and Votiva among others.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
